The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study

Introduction: The main driver for increased stroke prevalence is the aging of the population; however, the best evidenced-based strategies for stroke treatment and prevention are not always followed for older patients. Therefore, the aim was studying the association of age with clinical outcomes (mo...

Full description

Bibliographic Details
Main Authors: Natália Eduarda Furlan, Gustavo José Luvizutto, Pedro Tadao Hamamoto Filho, Silméia Garcia Zanati Bazan, Gabriel Pinheiro Modolo, Natalia Cristina Ferreira, Luana Aparecida Miranda, Juli Thomaz de Souza, Fernanda Cristina Winckler, Edison Iglesias de Oliveira Vidal, Carlos Clayton Macedo de Freitas, Luis Cuadrado Martin, Rodrigo Bazan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.649902/full
id doaj-a2eb33a054004480861798a62a5e1456
record_format Article
spelling doaj-a2eb33a054004480861798a62a5e14562021-07-06T15:18:03ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652021-07-011310.3389/fnagi.2021.649902649902The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort StudyNatália Eduarda Furlan0Gustavo José Luvizutto1Pedro Tadao Hamamoto Filho2Silméia Garcia Zanati Bazan3Gabriel Pinheiro Modolo4Natalia Cristina Ferreira5Luana Aparecida Miranda6Juli Thomaz de Souza7Fernanda Cristina Winckler8Edison Iglesias de Oliveira Vidal9Carlos Clayton Macedo de Freitas10Luis Cuadrado Martin11Rodrigo Bazan12Faculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilDepartamento de Fisioterapia Aplicada, Universidade Federal do Triângulo Mineiro, Uberaba, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilIntroduction: The main driver for increased stroke prevalence is the aging of the population; however, the best evidenced-based strategies for stroke treatment and prevention are not always followed for older patients. Therefore, the aim was studying the association of age with clinical outcomes (mortality and functional disability) in stroke patients who underwent cerebral reperfusion therapy at hospital discharge and 90 days after ictus.Methods: This was a retrospective (stroke databank analysis) cohort study of participants who had been diagnosed with ischemic stroke and undergone intravenous cerebral reperfusion therapy or mechanical thrombectomy. The variable of interest was patient age, which was categorized into four groups: (1) up to 59 years; (2) 60 to 69 years; (3) 70 to 79 years old; and (4) above 79 years. The primary outcome was mortality at hospital discharge and 90 days after stroke, and the secondary outcome was functional capacity at hospital discharge and 90 days after stroke.Results: A total of 281 patients was included in the study (235 treated by thrombolysis alone, and 46 treated with mechanical thrombectomy). The mean age of the total sample was 67 ± 13.1 years. The oldest patients had the most unfavorable outcomes, except for mortality rate, at hospital discharge (mRS > 2; OR: 1.028; 95% CI 1.005 to 1.051; p = 0.017; mRS > 3; OR: 1.043, 95% CI 1.018 to 1.069; p = 0.001) and 90 days after stroke (mRS > 2; OR: 1.028; 95% CI 1.005 to 1.051; p = 0.017; mRS > 3; OR: 1.043, 95% CI 1.018 to 1.069; p = 0.001).Conclusion: Cerebral reperfusion was a viable treatment for ischemic stroke in both elderly and very elderly patients, as it did not increase mortality. However, it was observed that older individuals had worse functional outcomes at hospital discharge and 90 days after stroke.https://www.frontiersin.org/articles/10.3389/fnagi.2021.649902/fullstrokecerebral reperfusionrtPAthrombectomyelderly
collection DOAJ
language English
format Article
sources DOAJ
author Natália Eduarda Furlan
Gustavo José Luvizutto
Pedro Tadao Hamamoto Filho
Silméia Garcia Zanati Bazan
Gabriel Pinheiro Modolo
Natalia Cristina Ferreira
Luana Aparecida Miranda
Juli Thomaz de Souza
Fernanda Cristina Winckler
Edison Iglesias de Oliveira Vidal
Carlos Clayton Macedo de Freitas
Luis Cuadrado Martin
Rodrigo Bazan
spellingShingle Natália Eduarda Furlan
Gustavo José Luvizutto
Pedro Tadao Hamamoto Filho
Silméia Garcia Zanati Bazan
Gabriel Pinheiro Modolo
Natalia Cristina Ferreira
Luana Aparecida Miranda
Juli Thomaz de Souza
Fernanda Cristina Winckler
Edison Iglesias de Oliveira Vidal
Carlos Clayton Macedo de Freitas
Luis Cuadrado Martin
Rodrigo Bazan
The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study
Frontiers in Aging Neuroscience
stroke
cerebral reperfusion
rtPA
thrombectomy
elderly
author_facet Natália Eduarda Furlan
Gustavo José Luvizutto
Pedro Tadao Hamamoto Filho
Silméia Garcia Zanati Bazan
Gabriel Pinheiro Modolo
Natalia Cristina Ferreira
Luana Aparecida Miranda
Juli Thomaz de Souza
Fernanda Cristina Winckler
Edison Iglesias de Oliveira Vidal
Carlos Clayton Macedo de Freitas
Luis Cuadrado Martin
Rodrigo Bazan
author_sort Natália Eduarda Furlan
title The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study
title_short The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study
title_full The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study
title_fullStr The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study
title_full_unstemmed The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study
title_sort impact of age on mortality and disability in patients with ischemic stroke who underwent cerebral reperfusion therapy: a brazilian cohort study
publisher Frontiers Media S.A.
series Frontiers in Aging Neuroscience
issn 1663-4365
publishDate 2021-07-01
description Introduction: The main driver for increased stroke prevalence is the aging of the population; however, the best evidenced-based strategies for stroke treatment and prevention are not always followed for older patients. Therefore, the aim was studying the association of age with clinical outcomes (mortality and functional disability) in stroke patients who underwent cerebral reperfusion therapy at hospital discharge and 90 days after ictus.Methods: This was a retrospective (stroke databank analysis) cohort study of participants who had been diagnosed with ischemic stroke and undergone intravenous cerebral reperfusion therapy or mechanical thrombectomy. The variable of interest was patient age, which was categorized into four groups: (1) up to 59 years; (2) 60 to 69 years; (3) 70 to 79 years old; and (4) above 79 years. The primary outcome was mortality at hospital discharge and 90 days after stroke, and the secondary outcome was functional capacity at hospital discharge and 90 days after stroke.Results: A total of 281 patients was included in the study (235 treated by thrombolysis alone, and 46 treated with mechanical thrombectomy). The mean age of the total sample was 67 ± 13.1 years. The oldest patients had the most unfavorable outcomes, except for mortality rate, at hospital discharge (mRS > 2; OR: 1.028; 95% CI 1.005 to 1.051; p = 0.017; mRS > 3; OR: 1.043, 95% CI 1.018 to 1.069; p = 0.001) and 90 days after stroke (mRS > 2; OR: 1.028; 95% CI 1.005 to 1.051; p = 0.017; mRS > 3; OR: 1.043, 95% CI 1.018 to 1.069; p = 0.001).Conclusion: Cerebral reperfusion was a viable treatment for ischemic stroke in both elderly and very elderly patients, as it did not increase mortality. However, it was observed that older individuals had worse functional outcomes at hospital discharge and 90 days after stroke.
topic stroke
cerebral reperfusion
rtPA
thrombectomy
elderly
url https://www.frontiersin.org/articles/10.3389/fnagi.2021.649902/full
work_keys_str_mv AT nataliaeduardafurlan theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT gustavojoseluvizutto theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT pedrotadaohamamotofilho theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT silmeiagarciazanatibazan theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT gabrielpinheiromodolo theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT nataliacristinaferreira theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT luanaaparecidamiranda theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT julithomazdesouza theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT fernandacristinawinckler theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT edisoniglesiasdeoliveiravidal theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT carlosclaytonmacedodefreitas theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT luiscuadradomartin theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT rodrigobazan theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT nataliaeduardafurlan impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT gustavojoseluvizutto impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT pedrotadaohamamotofilho impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT silmeiagarciazanatibazan impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT gabrielpinheiromodolo impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT nataliacristinaferreira impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT luanaaparecidamiranda impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT julithomazdesouza impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT fernandacristinawinckler impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT edisoniglesiasdeoliveiravidal impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT carlosclaytonmacedodefreitas impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT luiscuadradomartin impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
AT rodrigobazan impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy
_version_ 1721317225958211584